- |||||||||| p53MVA - Tara I / O
Trial completion, Trial completion date, Trial primary completion date, Combination therapy: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer (clinicaltrials.gov) - Apr 30, 2018 P1, N=12, Completed, Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Apr 2018 | Trial primary completion date: Jun 2019 --> Apr 2018 Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Apr 2018 | Trial primary completion date: Aug 2018 --> Apr 2018
- |||||||||| Trial completion, Licensing / partnership, Phase classification: Partnership for Healthy Seniors (clinicaltrials.gov) - Apr 26, 2018
P=N/A, N=2593, Completed, Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Apr 2018 | Trial primary completion date: Aug 2018 --> Apr 2018 Active, not recruiting --> Completed | Phase classification: P3 --> PN/A
- |||||||||| Trial completion: PCS: Preventing Congenital Syphilis (clinicaltrials.gov) - Apr 26, 2018
P=N/A, N=60386, Completed, Active, not recruiting --> Completed | Phase classification: P3 --> PN/A Active, not recruiting --> Completed
- |||||||||| pethidine / Samaritan
Trial completion, Trial completion date, Trial primary completion date, Head-to-Head: A Non-inferiority Trial on Pain Relief During Oocyte Retrieval (clinicaltrials.gov) - Apr 19, 2018 P4, N=170, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial completion date: Dec 2016 --> Feb 2018 | Trial primary completion date: Dec 2016 --> Feb 2018
- |||||||||| Enrollment closed, Enrollment change, Trial completion date: Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=14, Active, not recruiting, Not yet recruiting --> Completed | Trial completion date: Dec 2016 --> Feb 2018 | Trial primary completion date: Dec 2016 --> Feb 2018 Recruiting --> Active, not recruiting | N=95 --> 14 | Trial completion date: Dec 2017 --> Jun 2018
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: A Trial of Comparing the Pathology Status of Lymphoseek (clinicaltrials.gov) - Apr 18, 2018
P2, N=18, Terminated, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2018 N=40 --> 18 | Trial completion date: Oct 2018 --> Jul 2017 | Recruiting --> Terminated | Trial primary completion date: Oct 2018 --> Jul 2017; low accrual
- |||||||||| Trial completion: Vaginal vs. Laparoscopic Hysterectomy (clinicaltrials.gov) - Apr 17, 2018
P=N/A, N=100, Completed, N=40 --> 18 | Trial completion date: Oct 2018 --> Jul 2017 | Recruiting --> Terminated | Trial primary completion date: Oct 2018 --> Jul 2017; low accrual Active, not recruiting --> Completed
- |||||||||| Menopur (menotropin) / Ferring
Trial completion, Enrollment change: AMH and Dosing Regimens for Initial IVF Stimulation Protocols (clinicaltrials.gov) - Apr 12, 2018 P=N/A, N=78, Completed, Recruiting --> Completed | Trial completion date: Sep 2018 --> Apr 2018 Enrolling by invitation --> Completed | N=170 --> 78
- |||||||||| Trial completion, Metastases: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=247, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| metformin / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date, Combination therapy, Metastases: OVMET: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer (clinicaltrials.gov) - Apr 10, 2018 P1, N=15, Completed, Recruiting --> Completed | Phase classification: P1 --> P1/2 Recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2017 | Trial primary completion date: Mar 2019 --> Nov 2017
- |||||||||| Trial completion, Phase classification, Trial completion date, Trial primary completion date: Artificial Reproductive Techniques (ART) and Progression of Endometriosis Symptoms (clinicaltrials.gov) - Apr 6, 2018
P, N=154, Completed, Phase classification: P=N/A --> P | N=120 --> 25 | Enrolling by invitation --> Terminated; Low enrollment. Recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: May 2017 --> Apr 2018 | Trial primary completion date: Feb 2017 --> Apr 2018
- |||||||||| Trial completion date: Laparoscopic Approach to Cancer of the Endometrium (clinicaltrials.gov) - Apr 6, 2018
P3, N=760, Active, not recruiting, Recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: May 2017 --> Apr 2018 | Trial primary completion date: Feb 2017 --> Apr 2018 Trial completion date: Dec 2018 --> Dec 2019
- |||||||||| Phase classification: Genetic Causes of Male Infertility (clinicaltrials.gov) - Apr 6, 2018
P, N=400, Completed, Trial completion date: Dec 2018 --> Dec 2019 Phase classification: P=N/A --> P
- |||||||||| Phase classification: Global Study of Women's Health (clinicaltrials.gov) - Apr 6, 2018
P, N=1459, Completed, Phase classification: P=N/A --> P Phase classification: P=N/A --> P
- |||||||||| carboplatin / Generic mfg., paclitaxel / Generic mfg., dasatinib / Generic mfg.
Trial completion, Metastases: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (clinicaltrials.gov) - Apr 6, 2018 P1, N=18, Completed, Phase classification: P=N/A --> P | N=1000 --> 664 Active, not recruiting --> Completed
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Mobile Phone Technology to Increase Genetic Counseling (clinicaltrials.gov) - Mar 27, 2018
P=N/A, N=104, Completed, N=118 --> 1 | Trial completion date: Jun 2017 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Mar 2018; recruitment challenge Recruiting --> Completed | Trial completion date: Sep 2017 --> Feb 2018 | Trial primary completion date: Sep 2017 --> Feb 2018
- |||||||||| Phase classification, Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Metastases: Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer (clinicaltrials.gov) - Mar 27, 2018
P, N=2, Terminated, Recruiting --> Active, not recruiting Phase classification: P=N/A --> P | N=10 --> 2 | Trial completion date: Jun 2017 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: May 2017 --> Mar 2018
- |||||||||| Phase classification, Preclinical, Trial completion date, Trial primary completion date: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Mar 26, 2018
P, N=600, Active, not recruiting, Phase classification: P=N/A --> P | N=10 --> 2 | Trial completion date: Jun 2017 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: May 2017 --> Mar 2018 Phase classification: P=N/A --> P | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Jul 2018
|